Luxembourg Institute of Health

22/07/2026

Have you ever had orthopedic surgery, think you might need a joint replacement in the future, or manage a bone or joint condition?🤔

Are you a Luxembourg resident?🌍

At the Luxembourg Institute of Health, we are working on a project to develop "smart" implants embedded with tiny sensors to help doctors track a patient's healing progress.

We want to know what you think about this technology! We’ve launched a short online survey to gather public perspectives on data privacy, trust, and how these devices should be designed for patients.

💻 100% online
🕧Only takes 5–10 minutes
🔒 Completely anonymous (For Luxembourg residents & citizens)

👇 Share your thoughts and support local medical research here: https://ec.europa.eu/eusurvey/runner/SmILE_Patient_Survey

EUSurvey is an online survey-management system built for the creation and publishing of globally accessible forms, such as user satisfaction surveys and public consultations.

21/07/2026

📣 Help shape cancer research in Luxembourg 🔬

What matters most across Luxembourg's communities when making decisions about cancer treatment? That's what we want to understand, and we need your help.

We are running a short, anonymous survey (~10 minutes) that includes open-ended questions so you can share your experience in your own words.

You're warmly invited to take part if any of the following apply:

➡️ You were diagnosed with cancer at age 65 or older in Luxembourg
➡️A family member was diagnosed with cancer at age 65 or older in Luxembourg
➡️You are a caregiver for someone diagnosed with cancer at age 65 or older in Luxembourg
➡️You are a healthcare professional involved in cancer treatment or management for older adults (65+) in Luxembourg

The survey is available in: 🇬🇧 English · 🇫🇷 French · 🇩🇪 German · 🇱🇺 Luxembourgish · 🇵🇹 Portuguese

🔗https://lsurvey.lih.lu/index.php/576418?lang=en

Our study, TDM-Café, funded by Think Pink Lux and supported by Cargolux Airlines, is looking to hear from you!

06/07/2026

There’s still time to make a difference!💙

Your voice matters. By taking part, you can help shape the solutions of tomorrow for the rare disease community.

Interested in contributing? We'd love to hear from you.

📧 [email protected] or +352 26970-400

Learn more: https://www.lih.lu/en/icp4rare-en/

Every diagnostic journey is unique — could yours help develop new approaches to better support families facing a suspected rare disease.

If you are a parent or legal guardian of a child with a rare disease, or if you have been searching for a diagnosis for more than a year, you may be eligible to participate in this study 🔬

Why is your participation valuable?👇

Your experience helps us to:
• better understand the steps of the diagnostic journey
• identify needs that have not yet been fully explored
• develop approaches that are more aligned with the real experiences of families

Your participation involves a confidential one‑hour interview with our clinical research nurses.

Your voice matters. It helps shape the solutions of tomorrow 💙

Contact us to learn more about this study.
📧 [email protected] | 📞 +352 26970-400

More info: https://www.lih.lu/en/icp4rare-en/

The study is in collaboration with ALAN - Maladies Rares Luxembourg , Centre Hospitalier de Luxembourg, -Laboratoire national de santé, University of Luxembourg, Plan for Rare Diseases, Ern-Rnd European Reference Network for Rare Neurological Diseases

29/06/2026

“Our research shows that the air we breathe and the chemicals we are exposed to leave biological traces that shape chronic disease risk, contributing to conditions from cardiovascular diseases to neurodegeneration,” – Dr Brice Appenzeller, leader of the HBRU group 🌫️🧬

Read more about the impact of pollution and environmental exposures on disease in our Annual Report! 🧪 https://annual-report.lih.lu/

25/06/2026

🌍 Great insights on the future of precision medicine!
The XPOSE Doctoral Training Unit (DTU), under the coordination of the Department of Precision Health at the Luxembourg Institute of Health (LIH), recently hosted world-renowned exposome pioneer Prof. Gary W. Miller (Columbia University).

In his lecture "Exposomics Crosses the Rubicon", Prof. Miller highlighted why capturing the exposome (the sum of our environmental exposures, diet, and lifestyle) is the vital missing piece to fully understanding human health and transforming healthcare systems. 🧬🔬

It was a fantastic opportunity for the local scientific community and XPOSE PhD students to exchange ideas with a leading expert.

👇 Missed the seminar? Read the full recap here: https://bit.ly/4b74U8E and watch the recorded lecture here: https://youtu.be/EEhf5t1Q5kg?si=sm-pUSlstgkqnZPT

Thanks to the Luxembourg National Research Fund - FNR for supporting this initiative and the partners: the Department of Infection and Immunity (DII) of the LIH, the LISER - Luxembourg Institute of Socio-Economic Research, the Luxembourg Centre for Systems Biomedicine (LCSB) and the Faculty of Humanities, Education and Social Sciences (FHSE) of the University of Luxembourg

25/06/2026

Did you know? In 2025 we:

• Distributed 456,861 biological samples 🧪
• Collected and created 3,789,135 aliquots
• Published 311 scientific publications 📚
• Carried out 1,180 participant inclusions and follow-ups in collaborative research projects 🤝
• Filed 3 patent applications 💡
• Counted 546 employees from 58 nationalities 🌍
• Had 265 ongoing projects 🚀

Curious to know more? Discover more key facts and highlights in the LIH Annual Report 👉 https://annual-report.lih.lu/

23/06/2026

🇱🇺 Happy Nationalfeierdag!
Today, we celebrate collaboration: one of Luxembourg’s greatest strengths.
With the launch of the Luxembourg Research Clinic (LRC – Fuerschungsklinik Lëtzebuerg), LIH is proud to help bring together research, healthcare and the public to advance clinical research and improve the future of healthcare in Luxembourg.
Together, we can deliver impact far beyond our size.

More: http://researchclinic.lu/

Partners: University of Luxembourg, Centre Hospitalier du Nord, Hôpitaux Robert Schuman, Centre Hospitalier Emile Mayrisch, Centre Hospitalier de Luxembourg

19/06/2026

🕷️ Bitten by a tick? You could become allergic to red meat

A recent RTL Today report highlights alpha-gal syndrome, a delayed allergy to red meat that can develop after a tick bite.

At the Luxembourg Institute of Health (LIH), Dr Christiane Hilger and her team are conducting the ImmunoGal study to better understand why some people develop this allergy while others do not.

Alpha-gal syndrome can trigger symptoms several hours after eating mammalian meat such as beef, pork, venison or rabbit. These symptoms may include abdominal pain, nausea, itching, breathing difficulties and, in rare cases, severe allergic reactions.

👩‍🔬 To support this research, LIH is currently looking for adults who have recently been bitten by a tick.

To participate:
✔ You must be at least 18 years old
✔ You should contact LIH within 48 hours of detecting the tick bite
✔ Keep the tick and bring it to the consultation

Your participation can help researchers better understand the early immune response after tick bites and contribute to advances in allergy research.

📩 Contact us: [email protected]
📞 +352 26970-400

🔗 Read the RTL Today article and learn more about the ImmunoGal study: https://today.rtl.lu/news/science-and-environment/bitten-by-a-tick-you-could-become-allergic-to-red-meat-571137790

17/06/2026

“Clinnova has established a secure, interoperable and federated clinical research data network across Europe, enabling us to study diseases at a scale and depth never before possible” – Dr Jasmin Schulz, Clinnova project manager 🌍🔬

Read more about Clinnova in our Annual Report! 👇
https://annual-report.lih.lu/

15/06/2026

A proud moment for research!🧠✨

We are delighted to see the NORLUX Neuro-Oncology Laboratory at the Luxembourg Institute of Health contribute to a study published in Nature , one of the world’s most prestigious scientific journals 🌍🔬

This international collaboration represents an important step forward in understanding brain tumours and could help pave the way for more effective treatments in the future. 💙

👏 Congratulations to Anna Golebiewska and the entire NORLUX team for their outstanding contribution, as well as to all the researchers and partners involved in this remarkable achievement.

🚀 Advancing science through collaboration, innovation, and a shared commitment to improving patients’ lives.

🔗 Learn more via the link in our bio.

Research Innovation LIH NORLUX CancerResearch Healthcare ResearchImpact